Tracked deals
7
7 tracked deals across 2010-2025.
Public Company
Healthcare
Thermo Fisher Scientific
Waltham, Massachusetts, United States
Thermo Fisher Scientific Inc. is the world leader in serving science, with the mission to enable customers to make the world healthier, cleaner and safer. It delivers technologies, instruments, reagents, consumables, software/informatics, and laboratory/pharma services across life sciences research, diagnostics, and the development and manufacture of therapies.
- Focus Areas
- Life sciences research tools, Diagnostics, Laboratory instruments and consumables
- Website
- thermofisher.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
7 buyout
Thermo Fisher Scientific Acquisition Volume by Year
Last 6 years
Supporting Data
Recent Transactions
-
October 29, 2025
- Buyer
- Thermo Fisher Scientific Inc.
- Target
- Clario Holdings, Inc., Clario Holdings
- Seller
- Astorg, Nordic Capital, Novo Holdings, Cinven, a shareholder group led by Astorg, Nordic Capital, Novo Holdings, and Cinven
- Industry
- Healthcare Services
- Location
- United States
- Type
- Buyout
Thermo Fisher Scientific has agreed to acquire Clario Holdings, a digital clinical endpoint data solutions company, for $8.875 billion in cash plus up to $400 million in performance-based earnout payments. The deal is expected to close by mid-2026 pending regulatory approvals and would integrate Clario into Thermo Fisher’s Laboratory Products and Biopharma Services segment.
-
July 10, 2024
- Buyer
- Thermo Fisher Scientific Inc.
- Target
- Olink Holding AB (publ)
- Seller
- Summa Equity
- Industry
- Biotechnology
- Location
- Uppsala County, Sweden
- Type
- Buyout
Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.
-
- Buyer
- Thermo Fisher Scientific Inc.
- Target
- CorEvitas, LLC
- Seller
- Audax Private Equity
- Industry
- Data & Analytics
- Location
- Massachusetts, United States
- Type
- Buyout
Thermo Fisher Scientific agreed to acquire CorEvitas, a Waltham, Massachusetts–based real-world evidence (RWE) and clinical registries provider, from Audax Private Equity for $912.5 million in cash. The acquisition, completed August 14, 2023, will fold CorEvitas (approximately 300 employees; expected 2023 revenue ~$110M) into Thermo Fisher’s Laboratory Products and Biopharma Services segment to expand its RWE and life‑sciences data capabilities.
-
October 31, 2022
- Buyer
- Thermo Fisher Scientific Inc.
- Target
- The Binding Site Group
- Seller
- Shareholder group led by Nordic Capital
- Industry
- Medical Devices
- Location
- West Midlands, United Kingdom
- Type
- Buyout
Thermo Fisher Scientific has entered into a definitive agreement to acquire The Binding Site Group from a shareholder group led by Nordic Capital for £2.25 billion (about $2.6 billion). The Binding Site, a Birmingham-based specialist in protein and blood-cancer diagnostics with more than 1,100 employees and ~10% annual revenue growth, will join Thermo Fisher's Specialty Diagnostics segment to expand its capabilities in cancer diagnostics and monitoring.
-
- Buyer
- Thermo Fisher Scientific
- Target
- Brammer Bio
- Seller
- Ampersand Capital Partners, Brammer Bio founders
- Industry
- Biotechnology
- Location
- Massachusetts, United States
- Type
- Buyout
Thermo Fisher Scientific agreed to acquire Brammer Bio, a viral vector CDMO focused on gene and cell therapies, for approximately $1.7 billion in cash. The deal expands Thermo Fisher’s pharma services and viral vector manufacturing capabilities to support high-growth gene and cell therapy markets and brings a team of nearly 600 employees into its pharma services business.
-
March 6, 2017
- Buyer
- Thermo Fisher Scientific Inc.
- Target
- Core Informatics
- Industry
- Cloud & SaaS
- Location
- Connecticut, United States
- Type
- Buyout
Thermo Fisher Scientific has acquired Core Informatics, a Branford, Connecticut–based provider of cloud-based laboratory informatics platforms including LIMS, ELN and SDMS. The acquisition expands Thermo Fisher’s cloud and digital-lab capabilities by integrating Core’s Platform for Science into Thermo Fisher’s informatics and instrument ecosystem to better serve biopharma, genomics and industrial scientific customers.
-
February 2, 2010
- Buyer
- Thermo Fisher Scientific
- Target
- Finnzymes
- Industry
- Biotechnology
- Location
- Uusimaa, Finland
- Type
- Buyout
Thermo Fisher Scientific has signed a definitive agreement to acquire Finnzymes, a Finland-based provider of PCR enzymes, reagents, instruments and consumables. The acquisition expands Thermo Fisher's molecular biology and diagnostics portfolio by adding Finnzymes' proprietary DNA polymerases, miniaturized thermal cyclers and consumables; Finnzymes is headquartered in Espoo, Finland and had about 90 employees and $20 million revenue in 2009.
Related Acquisition Pages
Biotechnology Buyers & Acquisitions
3 tracked deals by Thermo Fisher Scientific.
Cloud & SaaS Buyers & Acquisitions
1 tracked deal by Thermo Fisher Scientific.
Data & Analytics Buyers & Acquisitions
1 tracked deal by Thermo Fisher Scientific.
Healthcare Services Buyers & Acquisitions
1 tracked deal by Thermo Fisher Scientific.
Acquisitions in Massachusetts
2 tracked deals by Thermo Fisher Scientific.
Acquisitions in Connecticut
1 tracked deal by Thermo Fisher Scientific.
Selling a company? Get in front of buyers like Thermo Fisher Scientific
Turn tracked acquisition activity into an outreach-ready buyer list.